Performance of free β-human chorionic gonadotrophin (free β-hCG) and pregnancy associated plasma protein-A (PAPP-A) analysis between Delfia Xpress and AutoDelfia systems in The Netherlands

Background: The VU University Medical Center (VUmc) was the first hospital in the Netherlands to introduce the Delfia Xpress for the analysis of free β-human chorionic gonadotrophin (β-hCG) and pregnancy associated plasma protein-A (PAPP-A) in the first trimester screening program for Down syndrome....

Full description

Saved in:
Bibliographic Details
Published inClinical chemistry and laboratory medicine Vol. 47; no. 2; pp. 222 - 226
Main Authors Linskens, Ingeborg H., Levitus, Marieke, Frans, Anneke, Schielen, Peter C.J.I., van Vugt, John M.G., Blankenstein, Marinus A., Dijstelbloem, Hilde M.
Format Journal Article
LanguageEnglish
Published Germany Walter de Gruyter 01.02.2009
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Background: The VU University Medical Center (VUmc) was the first hospital in the Netherlands to introduce the Delfia Xpress for the analysis of free β-human chorionic gonadotrophin (β-hCG) and pregnancy associated plasma protein-A (PAPP-A) in the first trimester screening program for Down syndrome. Since then, others have implemented this system. In this study, we tested the equality of measurements for free β-hCG and PAPP-A between Delfia Xpress systems and one AutoDelfia system. Methods: A total of 40 serum samples were aliquoted and stored at –20°C. Samples were analyzed by six Delfia Xpress systems and one AutoDelfia system over a time period of 2 years. Results: The relationships between free β-hCG and PAPP-A were excellent for the different Delfia Xpress systems (r>0.99, p<0.0001). For PAPP-A, the agreement between the main system at VUmc and five other systems was linear with slopes between 0.99 and 1.06. Similarly, agreement for free β-hCG was linear with slopes between 0.99 and 1.09. Likewise, agreement for PAPP-A and free β-hCG was excellent for the AutoDelfia vs. the main Delfia Xpress at the VUmc (r>0.99, p<0.0001). For both PAPP-A and free β-hCG, the relationships were linear with slopes of 1.08 and 1.07. Conclusions: We demonstrate an excellent agreement for the analysis of PAPP-A and free β-hCG between Delfia Xpress systems and one AutoDelfia system. Clin Chem Lab Med 2009;47:222–6.
AbstractList Background: The VU University Medical Center (VUmc) was the first hospital in the Netherlands to introduce the Delfia Xpress for the analysis of free β-human chorionic gonadotrophin (β-hCG) and pregnancy associated plasma protein-A (PAPP-A) in the first trimester screening program for Down syndrome. Since then, others have implemented this system. In this study, we tested the equality of measurements for free β-hCG and PAPP-A between Delfia Xpress systems and one AutoDelfia system. Methods: A total of 40 serum samples were aliquoted and stored at –20°C. Samples were analyzed by six Delfia Xpress systems and one AutoDelfia system over a time period of 2 years. Results: The relationships between free β-hCG and PAPP-A were excellent for the different Delfia Xpress systems (r>0.99, p<0.0001). For PAPP-A, the agreement between the main system at VUmc and five other systems was linear with slopes between 0.99 and 1.06. Similarly, agreement for free β-hCG was linear with slopes between 0.99 and 1.09. Likewise, agreement for PAPP-A and free β-hCG was excellent for the AutoDelfia vs. the main Delfia Xpress at the VUmc (r>0.99, p<0.0001). For both PAPP-A and free β-hCG, the relationships were linear with slopes of 1.08 and 1.07. Conclusions: We demonstrate an excellent agreement for the analysis of PAPP-A and free β-hCG between Delfia Xpress systems and one AutoDelfia system. Clin Chem Lab Med 2009;47:222–6.
: The VU University Medical Center (VUmc) was the first hospital in the Netherlands to introduce the Delfia Xpress for the analysis of free β-human chorionic gonadotrophin (β-hCG) and pregnancy associated plasma protein-A (PAPP-A) in the first trimester screening program for Down syndrome. Since then, others have implemented this system. In this study, we tested the equality of measurements for free β-hCG and PAPP-A between Delfia Xpress systems and one AutoDelfia system. : A total of 40 serum samples were aliquoted and stored at –20°C. Samples were analyzed by six Delfia Xpress systems and one AutoDelfia system over a time period of 2 years. : The relationships between free β-hCG and PAPP-A were excellent for the different Delfia Xpress systems (r>0.99, p<0.0001). For PAPP-A, the agreement between the main system at VUmc and five other systems was linear with slopes between 0.99 and 1.06. Similarly, agreement for free β-hCG was linear with slopes between 0.99 and 1.09. Likewise, agreement for PAPP-A and free β-hCG was excellent for the AutoDelfia vs. the main Delfia Xpress at the VUmc (r>0.99, p<0.0001). For both PAPP-A and free β-hCG, the relationships were linear with slopes of 1.08 and 1.07. : We demonstrate an excellent agreement for the analysis of PAPP-A and free β-hCG between Delfia Xpress systems and one AutoDelfia system. Clin Chem Lab Med 2009;47:222–6.
The VU University Medical Center (VUmc) was the first hospital in the Netherlands to introduce the Delfia Xpress for the analysis of free beta-human chorionic gonadotrophin (beta-hCG) and pregnancy associated plasma protein-A (PAPP-A) in the first trimester screening program for Down syndrome. Since then, others have implemented this system. In this study, we tested the equality of measurements for free beta-hCG and PAPP-A between Delfia Xpress systems and one AutoDelfia system. A total of 40 serum samples were aliquoted and stored at -20 degrees C. Samples were analyzed by six Delfia Xpress systems and one AutoDelfia system over a time period of 2 years. The relationships between free beta-hCG and PAPP-A were excellent for the different Delfia Xpress systems (r>0.99, p<0.0001). For PAPP-A, the agreement between the main system at VUmc and five other systems was linear with slopes between 0.99 and 1.06. Similarly, agreement for free beta-hCG was linear with slopes between 0.99 and 1.09. Likewise, agreement for PAPP-A and free beta-hCG was excellent for the AutoDelfia vs. the main Delfia Xpress at the VUmc (r>0.99, p<0.0001). For both PAPP-A and free beta-hCG, the relationships were linear with slopes of 1.08 and 1.07. We demonstrate an excellent agreement for the analysis of PAPP-A and free beta-hCG between Delfia Xpress systems and one AutoDelfia system.
Abstract : The VU University Medical Center (VUmc) was the first hospital in the Netherlands to introduce the Delfia Xpress for the analysis of free β-human chorionic gonadotrophin (β-hCG) and pregnancy associated plasma protein-A (PAPP-A) in the first trimester screening program for Down syndrome. Since then, others have implemented this system. In this study, we tested the equality of measurements for free β-hCG and PAPP-A between Delfia Xpress systems and one AutoDelfia system. : A total of 40 serum samples were aliquoted and stored at –20°C. Samples were analyzed by six Delfia Xpress systems and one AutoDelfia system over a time period of 2 years. : The relationships between free β-hCG and PAPP-A were excellent for the different Delfia Xpress systems (r>0.99, p<0.0001). For PAPP-A, the agreement between the main system at VUmc and five other systems was linear with slopes between 0.99 and 1.06. Similarly, agreement for free β-hCG was linear with slopes between 0.99 and 1.09. Likewise, agreement for PAPP-A and free β-hCG was excellent for the AutoDelfia vs. the main Delfia Xpress at the VUmc (r>0.99, p<0.0001). For both PAPP-A and free β-hCG, the relationships were linear with slopes of 1.08 and 1.07. : We demonstrate an excellent agreement for the analysis of PAPP-A and free β-hCG between Delfia Xpress systems and one AutoDelfia system. Clin Chem Lab Med 2009;47:222–6.
BACKGROUNDThe VU University Medical Center (VUmc) was the first hospital in the Netherlands to introduce the Delfia Xpress for the analysis of free beta-human chorionic gonadotrophin (beta-hCG) and pregnancy associated plasma protein-A (PAPP-A) in the first trimester screening program for Down syndrome. Since then, others have implemented this system. In this study, we tested the equality of measurements for free beta-hCG and PAPP-A between Delfia Xpress systems and one AutoDelfia system.METHODSA total of 40 serum samples were aliquoted and stored at -20 degrees C. Samples were analyzed by six Delfia Xpress systems and one AutoDelfia system over a time period of 2 years.RESULTSThe relationships between free beta-hCG and PAPP-A were excellent for the different Delfia Xpress systems (r>0.99, p<0.0001). For PAPP-A, the agreement between the main system at VUmc and five other systems was linear with slopes between 0.99 and 1.06. Similarly, agreement for free beta-hCG was linear with slopes between 0.99 and 1.09. Likewise, agreement for PAPP-A and free beta-hCG was excellent for the AutoDelfia vs. the main Delfia Xpress at the VUmc (r>0.99, p<0.0001). For both PAPP-A and free beta-hCG, the relationships were linear with slopes of 1.08 and 1.07.CONCLUSIONSWe demonstrate an excellent agreement for the analysis of PAPP-A and free beta-hCG between Delfia Xpress systems and one AutoDelfia system.
Author Dijstelbloem, Hilde M.
Linskens, Ingeborg H.
Frans, Anneke
Blankenstein, Marinus A.
Levitus, Marieke
Schielen, Peter C.J.I.
van Vugt, John M.G.
Author_xml – sequence: 1
  givenname: Ingeborg H.
  surname: Linskens
  fullname: Linskens, Ingeborg H.
  organization: Department of Obstetrics and Gynecology, VU University Medical Center, Amsterdam, The Netherlands
– sequence: 2
  givenname: Marieke
  surname: Levitus
  fullname: Levitus, Marieke
  organization: Department of Clinical Chemistry, VU University Medical Center, Amsterdam, The Netherlands
– sequence: 3
  givenname: Anneke
  surname: Frans
  fullname: Frans, Anneke
  organization: Department of Clinical Chemistry, VU University Medical Center, Amsterdam, The Netherlands
– sequence: 4
  givenname: Peter C.J.I.
  surname: Schielen
  fullname: Schielen, Peter C.J.I.
  organization: National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands
– sequence: 5
  givenname: John M.G.
  surname: van Vugt
  fullname: van Vugt, John M.G.
  organization: Department of Obstetrics and Gynecology, VU University Medical Center, Amsterdam, The Netherlands
– sequence: 6
  givenname: Marinus A.
  surname: Blankenstein
  fullname: Blankenstein, Marinus A.
  organization: Department of Clinical Chemistry, VU University Medical Center, Amsterdam, The Netherlands
– sequence: 7
  givenname: Hilde M.
  surname: Dijstelbloem
  fullname: Dijstelbloem, Hilde M.
  organization: Department of Clinical Chemistry, VU University Medical Center, Amsterdam, The Netherlands
BackLink https://www.ncbi.nlm.nih.gov/pubmed/19191730$$D View this record in MEDLINE/PubMed
BookMark eNptkc9u1DAQxiNURP_AkSvyCZVDlji240ScogAtYoFFCiriYjnJeJOS2IudqOS1-gA8As-E0121F-yDR-PffB7PdxocaaMhCJ7jaIUZZq-LYv1pFUdRtopo_Cg4wZTwkBKCj-5iGiZJjI-DU-euowgzRvmT4BhnfnMSnQR_NmCVsYPUNSCjkLIA6O9t2E4-herW2M7orkZbo2VjRmt2bafR-T1WXLxCUjdoZ2GrvciMpHOm7uQIPtlLN0h_Z0bodJij802-2YT5UiL72XUOVTDeAGj0FnrVSfTd6zh3p5hPozlk3exGGBzyL5ctoM8wtmB7D7mnwWMlewfPDudZ8O39u7K4DNdfLj4U-TqsSYrHkHOIMSQVMEoikiWcZhVXDcOgKAPAccTSKlaprOo0S0gcp1g1VHJWSZ5JxchZ8HKv6__yawI3iqFzNfS-CTCTE0mSpllMFzDcg7U1zllQYme7QdpZ4EgshonFMLEYJrxhnn9xEJ6qAZoH-uCQB97sgRvZj2Ab2Npp9oG4NpP1U3T_F6Y89uuhnc5P8Pe9urQ_RcIJZ-JrScVHwq7K8gcVV-QfRX64ZA
CitedBy_id crossref_primary_10_1002_pd_2300
crossref_primary_10_1515_CCLM_2010_005
crossref_primary_10_1002_pd_2873
crossref_primary_10_1002_pd_2775
crossref_primary_10_1002_pd_2494
crossref_primary_10_1002_pd_2495
crossref_primary_10_1080_15321819_2012_690358
crossref_primary_10_1016_j_labcli_2011_09_001
Cites_doi 10.1016/0140-6736(92)92073-O
10.1002/pd.1970150919
10.1046/j.1469-0705.1998.11060391.x
10.1073/pnas.96.6.3149
10.1093/clinchem/43.12.2323
10.1126/science.60782
10.1046/j.1469-0705.1999.13030167.x
10.1016/S0021-9258(18)31378-4
10.1177/000456329002700506
10.1093/clinchem/39.6.1064
10.1136/bmj.304.6831.867
10.1046/j.1469-0705.1999.13040231.x
10.1002/pd.1486
10.1016/0002-9378(74)90553-5
10.1002/(SICI)1097-0223(199702)17:2<185::AID-PD50>3.0.CO;2-M
10.1159/000230632
10.1210/jc.76.3.704
10.1002/pd.1791
10.1093/clinchem/39.10.2084
10.1258/000456303763046102
10.1016/S0009-9120(97)00095-7
10.1002/pd.1970141106
10.1093/clinchem/29.1.65
ContentType Journal Article
DBID BSCLL
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
DOI 10.1515/CCLM.2009.042
DatabaseName Istex
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
DatabaseTitleList

MEDLINE
CrossRef
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
EISSN 1437-4331
EndPage 226
ExternalDocumentID 10_1515_CCLM_2009_042
19191730
10_1515_CCLM_2009_042472222
ark_67375_QT4_K35WTTZ4_W
Genre Journal Article
Comparative Study
GeographicLocations Netherlands
GeographicLocations_xml – name: Netherlands
GroupedDBID ---
-~0
0R~
0~D
1CY
29B
354
36B
4.4
53G
5GY
5RE
9-L
AAAEU
AABBZ
AAEMA
AAFNC
AAFPC
AAGVJ
AALGR
AAONY
AAOQK
AAOTM
AAOWA
AAPJK
AAQCX
AASQH
AAWFC
AAXCG
AAZFL
ABAOT
ABAQN
ABFKT
ABFQV
ABIQR
ABJNI
ABLJU
ABMIY
ABPLS
ABPTK
ABRDF
ABRQL
ABUBZ
ABUVI
ABXMZ
ABYBW
ACEFL
ACGFS
ACIWK
ACMKP
ACPMA
ACPRK
ACTFP
ACXLN
ACZBO
ADALX
ADDWE
ADEQT
ADGQD
ADGYE
ADOZN
ADUQZ
AEDGQ
AEGVQ
AEICA
AEJTT
AEKEB
AENEX
AEQDQ
AERZL
AEXIE
AFAUI
AFBAA
AFBQV
AFCXV
AFGDO
AFGNR
AFQUK
AFRAH
AFYRI
AGBEV
AGGNV
AHOVO
AHVWV
AHXUK
AIERV
AIGSN
AIKXB
AJATJ
AJHHK
ALMA_UNASSIGNED_HOLDINGS
ALSKA
ALUKF
AMAVY
ASPBG
ASYPN
AVWKF
AZFZN
AZMOX
BAKPI
BBCWN
BCIFA
BSCLL
BWHEM
CAG
CGQUA
COF
CS3
DA2
DBYYV
DSRVY
DU5
EBS
EJD
EMOBN
EYIDJ
F5P
FSTRU
HZ~
IL9
IY9
N9A
O9-
OBC
OBS
OEB
OES
OHH
OVD
P2P
PQQKQ
QD8
RDG
SA.
SLJYH
TEORI
UK5
WTRAM
ZA5
~Z8
AGKVL
M48
PQEST
.55
.GJ
AAILP
ABVMU
ABWLS
AI.
AKXKS
ALYBR
CGR
CUY
CVF
ECM
EIF
KDIRW
NPM
VH1
X7M
AAYXX
CITATION
7X8
ID FETCH-LOGICAL-c381t-77e21e6be5430396749b7fd51ef45ee12058b2f8abc89632281fd4a75ba79af53
ISSN 1434-6621
IngestDate Fri Aug 16 11:18:02 EDT 2024
Thu Sep 12 18:43:47 EDT 2024
Sat Sep 28 07:52:13 EDT 2024
Fri Nov 25 00:40:37 EST 2022
Wed Jan 17 04:51:04 EST 2024
IsPeerReviewed true
IsScholarly true
Issue 2
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c381t-77e21e6be5430396749b7fd51ef45ee12058b2f8abc89632281fd4a75ba79af53
Notes ArticleID:cclm.2009.042
ark:/67375/QT4-K35WTTZ4-W
istex:8072EB4043102849468D0DE67C04B87F28CA6A47
cclm.2009.042.pdf
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 19191730
PQID 66889245
PQPubID 23479
PageCount 5
ParticipantIDs proquest_miscellaneous_66889245
crossref_primary_10_1515_CCLM_2009_042
pubmed_primary_19191730
walterdegruyter_journals_10_1515_CCLM_2009_042472222
istex_primary_ark_67375_QT4_K35WTTZ4_W
PublicationCentury 2000
PublicationDate 2009-02-01
PublicationDateYYYYMMDD 2009-02-01
PublicationDate_xml – month: 02
  year: 2009
  text: 2009-02-01
  day: 01
PublicationDecade 2000
PublicationPlace Germany
PublicationPlace_xml – name: Germany
PublicationTitle Clinical chemistry and laboratory medicine
PublicationTitleAlternate Clin Chem Lab Med
PublicationYear 2009
Publisher Walter de Gruyter
Publisher_xml – name: Walter de Gruyter
References Go AT (p_16) 2005; 149
p_23
p_24
p_25
Soini E (p_19) 1983; 29
Reynolds TM (p_15) 1990; 27
p_21
Oxvig C (p_7) 1993; 268
Qin QP (p_18) 1997; 43
p_2
p_1
p_12
p_3
p_13
p_6
p_14
p_5
Lin TM (p_4) 1974; 118
p_8
p_9
Passing H (p_20) 1983; 21
Spencer K (p_22) 1993; 39
Pettersson K (p_17) 1993; 39
p_10
p_11
References_xml – ident: p_12
  doi: 10.1016/0140-6736(92)92073-O
– ident: p_25
  doi: 10.1002/pd.1970150919
– ident: p_11
  doi: 10.1046/j.1469-0705.1998.11060391.x
– ident: p_8
  doi: 10.1073/pnas.96.6.3149
– volume: 149
  start-page: 2795
  year: 2005
  ident: p_16
  publication-title: Ned Tijdschr Geneeskd
  contributor:
    fullname: Go AT
– volume: 43
  start-page: 2323
  year: 1997
  ident: p_18
  publication-title: Clin Chem
  doi: 10.1093/clinchem/43.12.2323
  contributor:
    fullname: Qin QP
– ident: p_6
  doi: 10.1126/science.60782
– ident: p_1
  doi: 10.1046/j.1469-0705.1999.13030167.x
– volume: 268
  start-page: 12243
  year: 1993
  ident: p_7
  publication-title: J Biol Chem
  doi: 10.1016/S0021-9258(18)31378-4
  contributor:
    fullname: Oxvig C
– volume: 27
  start-page: 452
  year: 1990
  ident: p_15
  publication-title: Ann Clin Biochem
  doi: 10.1177/000456329002700506
  contributor:
    fullname: Reynolds TM
– volume: 39
  start-page: 1064
  year: 1993
  ident: p_22
  publication-title: Clin Chem
  doi: 10.1093/clinchem/39.6.1064
  contributor:
    fullname: Spencer K
– ident: p_10
  doi: 10.1136/bmj.304.6831.867
– ident: p_14
  doi: 10.1046/j.1469-0705.1999.13040231.x
– ident: p_9
  doi: 10.1002/pd.1486
– volume: 118
  start-page: 223
  year: 1974
  ident: p_4
  publication-title: Am J Obstet Gynecol
  doi: 10.1016/0002-9378(74)90553-5
  contributor:
    fullname: Lin TM
– ident: p_3
  doi: 10.1002/(SICI)1097-0223(199702)17:2<185::AID-PD50>3.0.CO;2-M
– ident: p_5
  doi: 10.1159/000230632
– volume: 21
  start-page: 709
  year: 1983
  ident: p_20
  publication-title: Part I. J Clin Chem Clin Biochem
  contributor:
    fullname: Passing H
– ident: p_2
  doi: 10.1210/jc.76.3.704
– ident: p_21
  doi: 10.1002/pd.1791
– volume: 39
  start-page: 2084
  year: 1993
  ident: p_17
  publication-title: Clin Chem
  doi: 10.1093/clinchem/39.10.2084
  contributor:
    fullname: Pettersson K
– ident: p_23
  doi: 10.1258/000456303763046102
– ident: p_24
  doi: 10.1016/S0009-9120(97)00095-7
– ident: p_13
  doi: 10.1002/pd.1970141106
– volume: 29
  start-page: 65
  year: 1983
  ident: p_19
  publication-title: Clin Chem
  doi: 10.1093/clinchem/29.1.65
  contributor:
    fullname: Soini E
SSID ssj0015547
Score 1.9584432
Snippet Background: The VU University Medical Center (VUmc) was the first hospital in the Netherlands to introduce the Delfia Xpress for the analysis of free β-human...
: The VU University Medical Center (VUmc) was the first hospital in the Netherlands to introduce the Delfia Xpress for the analysis of free β-human chorionic...
The VU University Medical Center (VUmc) was the first hospital in the Netherlands to introduce the Delfia Xpress for the analysis of free beta-human chorionic...
Abstract : The VU University Medical Center (VUmc) was the first hospital in the Netherlands to introduce the Delfia Xpress for the analysis of free β-human...
BACKGROUNDThe VU University Medical Center (VUmc) was the first hospital in the Netherlands to introduce the Delfia Xpress for the analysis of free beta-human...
SourceID proquest
crossref
pubmed
walterdegruyter
istex
SourceType Aggregation Database
Index Database
Publisher
StartPage 222
SubjectTerms AutoDelfia
Chorionic Gonadotropin, beta Subunit, Human - blood
Delfia Xpress
Down Syndrome - blood
Down Syndrome - diagnosis
first trimester Down syndrome screening
free β-human chorionic gonadotrophin
Humans
Immunoassay - instrumentation
Immunoassay - methods
Netherlands
Predictive Value of Tests
pregnancy associated plasma protein-A
Pregnancy-Associated Plasma Protein-A - analysis
Reagent Kits, Diagnostic
Reproducibility of Results
Sensitivity and Specificity
Title Performance of free β-human chorionic gonadotrophin (free β-hCG) and pregnancy associated plasma protein-A (PAPP-A) analysis between Delfia Xpress and AutoDelfia systems in The Netherlands
URI https://api.istex.fr/ark:/67375/QT4-K35WTTZ4-W/fulltext.pdf
http://www.degruyter.com/doi/10.1515/CCLM.2009.042
https://www.ncbi.nlm.nih.gov/pubmed/19191730
https://search.proquest.com/docview/66889245
Volume 47
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3ZbtNAFB2FRGJ5qKBsYZ0HhIoiQzyZ8fJoTEkFDQoipVFfrLEzTqNSJ0ocQfk8_od_4M7iJSVIwIsVTWaxdI6v7_XcewahZx6LU3vSTayu73YtGhN4pPyJbSUTkXDK7dRWIkmDD87BEX03ZuNG42cta2mdxy-T71vrSv4HVWgDXGWV7D8gW04KDfAb8IUrIAzXv8J4WMv6B6cvXQohE6-4pU_eA8u2nKkTbqbgb0P4uZwvTmcSba_WNezLLwNGL2Aq9TcuOtyABt7oAtzrc95Reg6zzArk6GEwHFqBHmY0TYp8rzfiSzrjnbHKr1WzBut8blq1bLTKwB2p3MqNYuNSMKEo1kyKw-jUPIauMifgckLAoTx-W2TG4E2lCZ1WVReH8O7P1ytTmTQTZ-U45bXrtM6s1vwpOZVl91mZv9wBppvPy8UHEr_IqS5tOu1Ry3F0IXZh9LXMpyE3qVtwXSb925uFKRGOMDwcGJFTutEPiLE4VzSDABhCYLPZtCnlXfx1BbWI6zPWRK2g_3r_c7ntBb6dOg2ouGMjCgtrv9pYWUnd6rk2_KmWNA3ftgVLN9DOV5V_MRHT5foiL_b7lRs1uol2TPyDA03mW6ghsl10LSyQ3kVXBwbc2-hHjd94nmJJWlzxG5f8xhv8xnu1jmH_BQb24JLbuOI21tzGJbfxnma2HKJ5jQ2vsWYw1rxWM1a8xobXGNYGXuMar--go7f7o_DAMmeOWAn4rjkEm4LYwokFo-Dc-Y5L_dhNJ8wWKWVC2KTLvJikHo8TD95dhHh2OqHcZTF3fZ6y3l3UzOaZuI9wShhPHAcC_JRTRn3e4x449HHPTRKPiF4bPS-QixZaWiaSITmgHUm05QmxfgRoQ0eFa9mLL89kPqbLoo8jGr3vsePR6IRGx230tAA-AtTk1h_PxHy9ihzH83xCWRvd03yoVjQ8aiN6iSCRsXSr7XclVWYJefDHCR-i69XT-Ag18-VaPAYHPo-fGNr_AiWY8xY
link.rule.ids 315,786,790,27955,27956
linkProvider Walter de Gruyter
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Performance+of+free+beta-human+chorionic+gonadotrophin+%28free+beta-hCG%29+and+pregnancy+associated+plasma+protein-A+%28PAPP-A%29+analysis+between+Delfia+Xpress+and+AutoDelfia+systems+in+The+Netherlands&rft.jtitle=Clinical+chemistry+and+laboratory+medicine&rft.au=Linskens%2C+Ingeborg+H&rft.au=Levitus%2C+Marieke&rft.au=Frans%2C+Anneke&rft.au=Schielen%2C+Peter+C+J+I&rft.date=2009-02-01&rft.issn=1434-6621&rft.volume=47&rft.issue=2&rft.spage=222&rft_id=info:doi/10.1515%2FCCLM.2009.042&rft_id=info%3Apmid%2F19191730&rft.externalDocID=19191730
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1434-6621&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1434-6621&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1434-6621&client=summon